Skip to main content
SpringerLink
Log in

Summary of clinical experience with recombinant factor VIII products — Kogenate

  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Schwartz RS, Abildgaard CF, Aledort LM et al. (1990) Human recombinant DNA-derived antihemophilic factor (FVIII) in the treatment of hemophilia A. N Engl J Med 323:1800–1805

    PubMed  Google Scholar 

  2. Lusher JM, Arkin S, Abildgaard CF, Schwartz RS and the Kogenate previously untreated patient study group (1993) Recombinant factor VIII for the treatment of previously untreated patients with hemophilia A. Safety, efficacy and development of inhibitors. N Engl J Med 328: 453–459

    PubMed  Google Scholar 

  3. Rousell R, Inwood M, Kasper CK et al. (1993) A protocol for immune tolerance induction utilizing recombinant FVIII (Kogenate). Thromb Haemost (abstract)

  4. Ehrenforth S, Kreuz W, Scharrer I et al. (1992) Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs. Lancet 339:594–598

    PubMed  Google Scholar 

  5. Addiego J, Kasper C, Abildgaard CF et al. (1993): Development of inhibitors in factor VIII-deficient hemophilia: comparison of frequency based upon treatment product. Lancet 342:462–464

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, Hematology/Oncology Division, Children's Hospital of Michigan, 48201, Detroit, MI, USA

    J. M. Lusher

Authors
  1. J. M. Lusher
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lusher, J.M. Summary of clinical experience with recombinant factor VIII products — Kogenate. Ann Hematol 68 (Suppl 3), S3–S6 (1994). https://doi.org/10.1007/BF01774521

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01774521

Keywords

Search

Navigation